I agree . Pretty cheap compared to other players in the market. Listed below some of the transactions in this space ( sourced from CHM presentation ).
Plenty of newsflow post listing too. Don’t forget company is in phase 1 trials , even a small reduction in tumour size will result in them passing phase 1. Very good risk vs reward here.
CHIMERIC THERAPEUTICS (CHM), who else is jumping on this big train of revenue.??, page-6
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
